The Sonic Healthcare Ltd (ASX: SHL) share price is in focus today after the company reported strong financial results for the year ended 30 June 2026, with revenue rising 13% to $10.87 billion and underlying net profit up 17% to $621 million.
What did Sonic Healthcare report?
- Revenue: $10,867 million, up 13% from FY2025
- Underlying EBITDA: $1,933 million, up 11%
- Underlying net profit after tax (NPAT): $621 million, up 17%
- Earnings per share: 125.6 cents, up 14%
- Total dividend: $1.08 per share (final dividend $0.63, franked to 60%)
- Strong organic revenue growth of 5%
What else do investors need to know?
Sonic Healthcare completed several strategic acquisitions during FY2026, including major German provider LADR and Cairo Diagnostics. The integration of these businesses is on track, with over 40% of expected synergies realised in year one for LADR. The company has also continued to sharpen its focus on advanced diagnostics, with standout growth in its genetics and specialist pathology businesses, both in Australia and internationally.
Management is investing in the digital and AI transformation of core systems. Around $30 million per year is earmarked over the next three years to modernise finance, supply chain and HR, supporting future productivity. Meanwhile, a $445 million sale and leaseback of its Brisbane hub laboratory strengthened Sonic Healthcare’s balance sheet and capital flexibility.
What’s next for Sonic Healthcare?
Looking ahead to FY2027, Sonic Healthcare expects continued organic growth across its major markets, underpinned by demand for personalised and preventative healthcare. The company has provided EBITDA guidance in the range of $1,950 million to $2,030 million (constant currency), excluding costs from its IT transformation program. Some earnings headwinds are anticipated from regulatory changes in Switzerland and a slower ramp-up of profit from its large UK NHS contract.
The group intends to continue progressing US operational improvements, realise further synergy benefits from its recent acquisitions, and optimise costs through automation and strategic procurement.
Sonic Healthcare share price snapshot
It has been a tough 12 months for the Sonic Healthcare share price. During this time, the company’s shares have underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of 18%.
The post Sonic Healthcare share price in focus on FY26 profit jump and digital push appeared first on The Motley Fool Australia.
Should you invest $1,000 in Sonic Healthcare right now?
Before you buy Sonic Healthcare shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sonic Healthcare wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 August 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Here are the top 10 ASX 200 shares today
- Buy, hold, sell: Sonic Healthcare, AMP, CBA shares
- 8 ASX 200 shares with fresh buy ratings this week
- Why this ASX healthcare stock is a top rebound candidate with big upsideÂ
- How much superannuation is needed to target $8,000 per month in passive income?
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.